Lipella Pharmaceuticals Common Stock Price on December 16, 2024
| LIPO Stock | 2.76 0.06 2.22% |
If you're considering investing in Lipella Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lipella Pharmaceuticals stands at 2.76, as last reported on the 18th of December 2024, with the highest price reaching 2.79 and the lowest price hitting 2.64 during the day. Lipella Pharmaceuticals has Sharpe Ratio of -0.0133, which conveys that the firm had a -0.0133% return per unit of risk over the last 3 months. Lipella Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lipella Pharmaceuticals' Mean Deviation of 5.05, risk adjusted performance of (0.0003), and Standard Deviation of 7.08 to check out the risk estimate we provide.
At this time, Lipella Pharmaceuticals' Common Stock Shares Outstanding is very stable compared to the past year. As of the 18th of December 2024, Common Stock is likely to grow to 712.80, while Total Stockholder Equity is likely to drop about 2.1 M. . At this time, Lipella Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 18th of December 2024, Price Book Value Ratio is likely to grow to 16.36, while Price Earnings Ratio is likely to drop (11.14). Lipella Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lipella |
Sharpe Ratio = -0.0133
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LIPO |
Estimated Market Risk
| 7.11 actual daily | 63 63% of assets are less volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lipella Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lipella Pharmaceuticals by adding Lipella Pharmaceuticals to a well-diversified portfolio.
Price Book 2.2373 | Enterprise Value Ebitda (4.40) | Price Sales 6.4354 | Shares Float 650.8 K | Wall Street Target Price 16 |
Related Headline
Senti Biosciences Headline on 16th of December 2024
Senti Bio Announces First Patient Dosed in Clinical Trial of... by finance.yahoo.com
Dose-finding clinical trial in China designed to evaluate safety and preliminary anti-tumor activity of SN301A in hepatocellular carcinoma SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 -- Senti Biosciences, Inc. , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that the first patient has been dosed in the p
Lipella Pharmaceuticals Valuation on December 16, 2024
It is possible to determine the worth of Lipella Pharmaceuticals on a given historical date. On December 16, 2024 Lipella was worth 2.57 at the beginning of the trading date compared to the closed value of 2.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lipella Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Lipella Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lipella Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lipella Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.58 | 2.66 | 2.53 | 2.54 | 32,455 | |
12/16/2024 | 2.57 | 2.70 | 2.56 | 2.70 | 21,602 |
| 2.72 | 2.79 | 2.64 | 2.76 | 45,666 |
| Backtest Lipella Pharmaceuticals | | | Lipella Pharmaceuticals History | | | Lipella Pharmaceuticals Valuation | Previous | Next |
Lipella Pharmaceuticals Trading Date Momentum on December 16, 2024
| On December 17 2024 Lipella Pharmaceuticals Common was traded for 2.76 at the closing time. The top price for the day was 2.79 and the lowest listed price was 2.64 . The trading volume for the day was 45.7 K. The trading history from December 17, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 2.22% . The trading delta at closing time against the current closing price is 0.74% . |
Lipella Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Lipella Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lipella Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lipella financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lipella Pharmaceuticals Stock history
Lipella Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lipella is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lipella Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lipella Pharmaceuticals stock prices may prove useful in developing a viable investing in Lipella Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6 M | 6.4 M | |
| Net Loss | -2.3 M | -2.2 M |
Lipella Pharmaceuticals Stock Technical Analysis
Lipella Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lipella Pharmaceuticals Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Lipella Pharmaceuticals Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lipella Pharmaceuticals December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Lipella Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lipella Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Lipella Pharmaceuticals stock market strength indicators, traders can identify Lipella Pharmaceuticals Common entry and exit signals to maximize returns
Lipella Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lipella Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Lipella Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lipella to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.0003) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.88) | Revenue Per Share 0.592 | Quarterly Revenue Growth 0.279 | Return On Assets (0.94) | Return On Equity (1.72) |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.